Maozhong Li
China Food and Drug Administration
1 Papers
21 Citations
Maozhong Li is an academic researcher from China Food and Drug Administration. The author has contributed to research in topics: Supply chain. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Risk assessment of supply chain for pharmaceutical excipients with AHP-fuzzy comprehensive evaluation.
TL;DR: It was concluded that polysorbate 80 for injection use is a high-risk ingredient in the supply chain compared to that for oral use to achieve safety application in clinic, thus measures should be taken to control and minimize those risks.